William Plovanic
Stock Analyst at Canaccord Genuity
(3.08)
# 963
Out of 4,944 analysts
143
Total ratings
43.31%
Success rate
0.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $331 → $353 | $308.68 | +14.36% | 4 | Aug 8, 2025 | |
| AORT Artivion | Maintains: Buy | $35 → $41 | $43.73 | -6.24% | 2 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $59 → $24 | $11.13 | +115.63% | 5 | Aug 7, 2025 | |
| STIM Neuronetics | Maintains: Buy | $8 → $7 | $3.87 | +80.88% | 4 | Aug 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $139 → $170 | $166.86 | +1.88% | 11 | Aug 1, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 | $79.96 | +32.57% | 7 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $75 → $81 | $77.68 | +4.27% | 27 | Jul 25, 2025 | |
| GMED Globus Medical | Maintains: Buy | $97 → $90 | $62.79 | +43.33% | 4 | Jul 22, 2025 | |
| ANGO AngioDynamics | Maintains: Buy | $15 → $17 | $9.06 | +87.64% | 7 | Jul 16, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $129 → $142 | $132.04 | +7.54% | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $103.22 | -2.15% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $18 | $7.73 | +132.86% | 8 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $3.70 | +197.30% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $52 | $36.70 | +41.69% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $11.94 | +176.50% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $117 | $102.50 | +14.15% | 10 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.53 | +99.20% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $257.38 | +10.34% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $15.80 | +58.23% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.54 | +679.22% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $86.15 | -18.75% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $28.21 | +70.15% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $8.51 | +158.52% | 3 | Jul 25, 2023 |
Insulet
Aug 8, 2025
Maintains: Buy
Price Target: $331 → $353
Current: $308.68
Upside: +14.36%
Artivion
Aug 8, 2025
Maintains: Buy
Price Target: $35 → $41
Current: $43.73
Upside: -6.24%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Buy
Price Target: $59 → $24
Current: $11.13
Upside: +115.63%
Neuronetics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.87
Upside: +80.88%
iRhythm Technologies
Aug 1, 2025
Maintains: Buy
Price Target: $139 → $170
Current: $166.86
Upside: +1.88%
DexCom
Aug 1, 2025
Maintains: Buy
Price Target: $106
Current: $79.96
Upside: +32.57%
Edwards Lifesciences
Jul 25, 2025
Maintains: Hold
Price Target: $75 → $81
Current: $77.68
Upside: +4.27%
Globus Medical
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $62.79
Upside: +43.33%
AngioDynamics
Jul 16, 2025
Maintains: Buy
Price Target: $15 → $17
Current: $9.06
Upside: +87.64%
TransMedics Group
Jul 15, 2025
Maintains: Buy
Price Target: $129 → $142
Current: $132.04
Upside: +7.54%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $103.22
Upside: -2.15%
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $7.73
Upside: +132.86%
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $3.70
Upside: +197.30%
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $36.70
Upside: +41.69%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $11.94
Upside: +176.50%
Feb 6, 2025
Maintains: Buy
Price Target: $101 → $117
Current: $102.50
Upside: +14.15%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.53
Upside: +99.20%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $257.38
Upside: +10.34%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $15.80
Upside: +58.23%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.54
Upside: +679.22%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $86.15
Upside: -18.75%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $28.21
Upside: +70.15%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $8.51
Upside: +158.52%